{"chunk_id": "medquad__chunk_47442", "source": "medquad", "text": "- adalimumab  - certolizumab  - infliximab  - natalizumab  - vedolizumab\n                \nHealth care providers most often give patients infliximab every 6 to 8 weeks at a hospital or an outpatient center. Side effects may include a toxic reaction to the medication and a higher chance of developing infections, particularly tuberculosis.\n                \nOther medications to treat symptoms or complications may include\n                \n- acetaminophen for mild pain. People with Crohn's dis"}